SCHEMBL16625600

SCHEMBL16625600

Cc1ccc(NC(=O)c2cccnc2Nc2ccccc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.84
KMT2A Q03164 8/20 0.84
MAPT P10636 6/20 0.84
ALDH1A1 P00352 2/20 0.84
GAA P10253 2/20 0.84
RAB9A P51151 7/20 0.75
NPSR1 Q6W5P4 2/20 0.75
MAPK1 P28482 1/20 0.75
NPC1 O15118 5/20 0.67
SMN1; SMN2 Q16637 5/20 0.67
AHR P35869 1/20 0.67
KDM4E B2RXH2 3/20 0.64
KDR P35968 2/20 0.63
DHODH Q02127 4/20 0.62
CASP3 P42574 1/20 0.60
SENP8 Q96LD8 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
SENP6 Q9GZR1 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.56
LMNA P02545 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9075528 0.92 MEN1 (1.00) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL12431830 0.84 DHODH (0.77) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL18979213 0.84 MEN1 (0.78) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL15528907 0.84 MEN1 (0.78) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL12561360 0.83 MEN1 (0.68) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL16007507 0.83 KDR (0.88) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL16625628 0.82 KDR (0.84) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL16017736 0.81 KDR (0.70) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL14368225 0.81 KDM4E (0.64) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL846930 0.81 DHODH (0.76) MEN1KMT2AMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150099758-A1 Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof ANVYL LLC (US) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099758-A1 Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof CHRNA7, CHRNA1, CHRNA2 MEN1 4409/4885KMT2A 2959/4885MAPT 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.